← Open Payments lookup

GINA ESPARZA: Open Payments

NPI 1679506521 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$623 in 30 payments from 12 companies in 2025. Trend: 2023 $513 · 2024 $633 · 2025 $623

Food & beverage: $623
CompanyPaymentsAmount
Novo Nordisk Inc15$261
Smith+Nephew, Inc.1$124
Abbott Laboratories3$73
ABBVIE INC.2$30
Cipher Pharmaceuticals US LLC1$21
CVRx, Inc.1$20
Sumitomo Pharma America, Inc.1$17
Lundbeck LLC1$17
Bayer Healthcare Pharmaceuticals Inc.1$17
Lilly USA, LLC1$15

Products named: Ozempic, COLLAGENASE SANTYL, FREESTYLE LIBRE 3, Rybelsus, Natroba, Barostim Neo System, Wegovy, GEMTESA.

Industry payments across TX — which companies pay providers there.